Dr. Carolina Schinke

Dr. Carolina Schinke, MD, is a board-certified hematologist-oncologist specializing in plasma cell disorders, with a particular focus on multiple myeloma and amyloidosis. She serves as Associate Professor of Medicine at the University of Arkansas for Medical Sciences (UAMS), where she is a core faculty member at the Myeloma Center, one of the leading global institutions for myeloma research and care. Dr. Schinke earned her medical degree from Martin Luther University in Halle, Germany, completed her internal medicine residency at Jacobi Medical Center in New York, and pursued fellowship training in hematology and oncology at Montefiore Medical Center.

Dr. Schinke’s research is focused on improving outcomes for patients with relapsed and refractory multiple myeloma through the development of novel immunotherapies and targeted agents. She has served as a principal investigator on several clinical trials investigating bispecific antibodies, monoclonal antibodies, and cellular therapies, contributing to the clinical advancement of agents such as talquetamab and teclistamab. Her work has been presented at national meetings and published in peer-reviewed journals, and she remains actively involved in translating scientific innovation into improved patient care.

In addition to her clinical and research responsibilities, Dr. Schinke is a dedicated educator and mentor at UAMS. She works closely with hematology-oncology fellows and junior faculty, supporting their development through clinical teaching and collaborative research. Through her commitment to scientific progress, mentorship, and patient-centered care, Dr. Carolina Schinke continues to advance the field of multiple myeloma and improve outcomes for patients with complex hematologic malignancies.